These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Was the danger of diet pills overstated? Harv Heart Lett; 2000 Feb; 10(6):4-5. PubMed ID: 10799141 [No Abstract] [Full Text] [Related]
7. A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination. Weintraub M; Hasday JD; Mushlin AI; Lockwood DH Arch Intern Med; 1984 Jun; 144(6):1143-8. PubMed ID: 6375610 [TBL] [Abstract][Full Text] [Related]
8. Fenfluramine and phentermine. Howlin D Ann Intern Med; 2001 Nov; 135(9):840-1. PubMed ID: 11694113 [No Abstract] [Full Text] [Related]
9. Cerebral hemorrhage in a patient taking fenfluramine and phentermine for obesity. Wen PY; Feske SK; Teoh SK; Stieg PE Neurology; 1997 Aug; 49(2):632-3. PubMed ID: 9270617 [No Abstract] [Full Text] [Related]
10. Valve disease and diet pills--where do we stand? Aurigemma GP; Gaasch WH Am Fam Physician; 1998 Feb; 57(4):656, 659-60. PubMed ID: 9490990 [No Abstract] [Full Text] [Related]
12. Regression of multivalvular regurgitation after the cessation of fenfluramine and phentermine treatment. Cannistra LB; Cannistra AJ N Engl J Med; 1998 Sep; 339(11):771. PubMed ID: 9742026 [No Abstract] [Full Text] [Related]
13. Report links appetite suppressants with heart disease. FDA encourages reporting of like events. Am J Health Syst Pharm; 1997 Aug; 54(16):1785, 1788. PubMed ID: 9269513 [No Abstract] [Full Text] [Related]
14. Withdrawal depression in obese patients after fenfluramine treatment. Steel JM; Briggs M Br Med J; 1972 Jul; 3(5817):26-7. PubMed ID: 5039550 [TBL] [Abstract][Full Text] [Related]
15. Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine/fenfluramine. Gardin JM; Schumacher D; Constantine G; Davis KD; Leung C; Reid CL JAMA; 2000 Apr; 283(13):1703-9. PubMed ID: 10755496 [TBL] [Abstract][Full Text] [Related]
16. Long-term weight control study. III (weeks 104 to 156). An open-label study of dose adjustment of fenfluramine and phentermine. Weintraub M; Sundaresan PR; Schuster B; Moscucci M; Stein EC Clin Pharmacol Ther; 1992 May; 51(5):602-7. PubMed ID: 1587074 [TBL] [Abstract][Full Text] [Related]
17. Dose effect of fenfluramine-phentermine in the production of valvular heart disease. Tovar EA; Landa DW; Borsari BE Ann Thorac Surg; 1999 Apr; 67(4):1213-4. PubMed ID: 10320298 [No Abstract] [Full Text] [Related]
18. In search of a 'magic' pill to treat obesity: the rise and fall of 'Fen-Phen'. Capriotti T Medsurg Nurs; 1998 Feb; 7(1):52-4. PubMed ID: 9544011 [No Abstract] [Full Text] [Related]
19. Clinical and echocardiographic follow-up of patients previously treated with dexfenfluramine or phentermine/fenfluramine. Gardin JM; Weissman NJ; Leung C; Panza JA; Fernicola D; Davis KD; Constantine GD; Reid CL JAMA; 2001 Oct 24-31; 286(16):2011-4. PubMed ID: 11667938 [TBL] [Abstract][Full Text] [Related]
20. Regression and progression of valvulopathy associated with fenfluramine and phentermine. Dahl CF; Allen MR Ann Intern Med; 2002 Mar; 136(6):489. PubMed ID: 11900508 [No Abstract] [Full Text] [Related] [Next] [New Search]